Cryo Cell International (CCEL) Gross Profit (2010 - 2026)

Cryo Cell International (CCEL) has reported Gross Profit for 17 consecutive years, with $6.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Gross Profit changed 0.45% year-over-year to $6.1 million; the TTM figure through May 2026 stood at $24.3 million (down 0.52% YoY), while the FY2025 annual figure was $24.2 million, up 0.63% from the prior year.
• Gross Profit grew to $6.1 million in Q2 2026 per CCEL's latest filing, from $6.0 million in the prior quarter.
• Across five years, Gross Profit topped out at $6.4 million in Q4 2024 and bottomed at $5.2 million in Q1 2022.
• Historically, Gross Profit has averaged $5.8 million across 5 years, with a median of $5.9 million in 2023.
• Annual changes were most pronounced in 2022 — Gross Profit grew 12.07% — and 2025, when it fell 4.36%.
• Cryo Cell International's Gross Profit stood at $5.6 million in 2022, then grew by 4.05% to $5.9 million in 2023, then grew by 9.13% to $6.4 million in 2024, then declined by 4.36% to $6.1 million in 2025, then fell by 0.16% to $6.1 million in 2026.
• Business Quant data shows CCEL's Gross Profit at $6.1 million in Q2 2026, $6.0 million in Q1 2026, and $6.1 million in Q4 2025.